Market Intelligence
Clinical Research
in Latin America
A growing market. A strategic opportunity.
The right partner makes all the difference.
The Opportunity
Why Latin America?
Latin America has established itself as one of the most strategically important regions for global clinical research. With over 650 million people across diverse ethnic backgrounds and disease presentations, the region offers sponsors access to patient profiles that are increasingly difficult to find in saturated North American or European markets.
Beyond patient access, LATAM offers lower treatment exposure, high protocol compliance, motivated investigators, and growing regulatory sophistication. For sponsors who know how to navigate the region, it can meaningfully accelerate timelines and reduce costs without compromising data quality.
The challenge is navigation. Each country has its own regulatory framework, its own health authority, its own cultural and operational dynamics. That is where local expertise becomes not just helpful, but essential.
The Market
Why Mexico?
Your Partner
Navigating LATAM takes local expertise.
Executing a study in Mexico requires deep familiarity with the regulatory environment, established investigator relationships, and operational knowledge that cannot be acquired from a distance. Althian has been operating in this market for over 15 years β we know the regulators, the investigators, and the challenges.
When you work with Althian, you are partnering with a team that has spent over a decade and a half building expertise in this market. We don't just know LATAM β we live and work here every day.